Building access to the Regenstrief Institute is restricted through early 2021. More on our coronavirus precautions.
See our coronavirus precautions.

Regenstrief Institute research scientist Michael “Mick” Murray, PharmD, MPH, is retiring after decades of groundbreaking work. He has been with the institute for 34 years while pioneering in the field of pharmacoepidemiology. He is the Purdue College of Pharmacy Distinguished Professor of Pharmacy Practice and Endowed Chair of Medication Safety.

Dr. Murray began work at Regenstrief in 1986, holding the first Regenstrief-Purdue fellowship in pharmacoepidemiology. He served as the director of the institute’s Health Data & Epidemiology Section from 1996 to 2004 and as the executive director of the institute’s Center for Healthcare Effectiveness Research from 2010 to 2015 while also directing the Regenstrief Data Core (now known as Regenstrief Data Services).

His research focused on improving medication uses and safety in individuals with chronic disease. Dr. Murray developed pharmacy services to improve drug therapy in older adults with chronic disorders and applied pharmacoepidemiology using large population computer databases.

Through more than 130 publications, Dr. Murray substantively advanced the understanding of medication safety, adherence and epidemiology in burdensome medical conditions such as heart failure, hypertension, and dementia.

Dr. Murray is a member of the National Academy of Medicine’s Clinical Effectiveness Research Innovation Collaborative and the World Health Organization’s Committee for Global Patient Safety Challenge on Medication Safety. He has served on the boards of the American Society for Clinical Pharmacology & Therapeutics, the International Society for Pharmacoepidemiology (in which he is a fellow and charter member), and the United States Pharmacopeia. He has won countless awards, including Indiana Public Health Foundation’s Excellence in Health Science Research Award and John M. Eisenberg Memorial Lectureship on Therapeutics Research from the Agency for Health Care Research and Quality.

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org
(317) 643-2313
Cindy Fox Aisen
Regenstrief Institute
caisen@regenstrief.org
(317) 843-2275

Related News

Sep 15, 2020 • News
Study offers real world perspective on how Black patients experience mental healthcare
Research provides insight into how perceptions of bias affect engagement with providers In a novel study the authors hope will contribute to improved patient care, Richard L. Roudebush Veterans Affairs Medical Center and Regenstrief Institute researchers examine how Black patients with mental health concerns evaluate verbal and non-verbal communication during treatment. Drawing upon information gathered…
Continue Reading >
Sep 11, 2020 • News
Addiction crisis continues amid COVID-19: Regenstrief scientist addressing needs through community health workers
As the world deals with the COVID-19 pandemic, millions of Americans continue to battle substance use disorder. September is National Recovery Month, and Indiana University is celebrating the faculty who are leading the effort to help people recover. Debra Litzelman, M.D., M.A., associate director of the Regenstrief Institute Center for Health Services Research, is leading…
Continue Reading >